(Q34553361)

English

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

Kathleen M Schmainda

object named as

Kathleen M Schmainda

7

0 references

author name string

Benjamin M Ellingson

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mark G Malkin

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Scott D Rand

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Pete S LaViolette

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jennifer M Connelly

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Wade M Mueller

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

27 August 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

95-103

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Factors affecting perceived tumor volumes in magnetic resonance imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Imaging of gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

7 July 2018

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

How often are nonenhancing supratentorial gliomas malignant? A population study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Magnetic resonance of the brain: the optimal screening technique

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Fast fluid-attenuated inversion-recovery (FLAIR) MRI in the assessment of intraaxial brain tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0293-7

21 January 2018

Vanishing contrast enhancement in malignant glioma after corticosteroid treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

27 October 2018

The role of diffusion-weighted imaging in patients with brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

27 October 2018

Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

27 October 2018

Preliminary evaluation of fluid-attenuated inversion-recovery MR in the diagnosis of intracranial tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

27 October 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3033973

27 October 2018

Real-time 3D image registration for functional MRI

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of peritumoural oedema and the effect of steroids using NMR-relaxation time imaging and blood-brain barrier analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T

1 reference

https://pubmed.ncbi.nlm.nih.gov/20798977

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-010-0293-7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

release_ovc2tdletjdifm7k6wewgvkjv4

1 reference

https://api.fatcat.wiki/v0/release/ovc2tdletjdifm7k6wewgvkjv4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34553361&oldid=2196774143"